Blogs

Follow the Money

Brad Setser tracks cross-border flows, with a bit of macroeconomics thrown in.

Latest Post

Better Late Than Never: The IMF Starts to Recognizes Balance of Payments Reality

The IMF marked its assessment of external imbalances to market, but its model and approach still struggle to get China right.

Read More
China
The Case that China is Now Actively Resisting Pressure on the Yuan to Appreciate
Chinese state banks have been consistently accumulating foreign assets. The direction of pressure on China’s currency has changed; without backdoor intervention, it would now be getting stronger.
China
China’s Stealth Trade Surplus
China’s surplus wears an invisibility cloak; it disappears in the IMF’s eyes.
Taiwan
A New Impediment to Balance of Payments Adjustment: Underwater Bonds
Taiwanese insurers are locked into holding U.S. dollar bonds that trade below par, putting pressure on Taiwan’s central bank to intervene to block currency adjustment to preserve their capital.
  • Economics
    Time to End Roundtripping by Big Pharma
    U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.
  • Economics
    The Dollar’s Global Role and the Financing of the U.S. External Deficit
    There is too much talk about the dollar’s role as a reserve currency and too little talk about expectations of exceptional returns. Reserve accumulation hasn’t driven the financing of the U.S. current account deficit in recent years.
  • Europe
    Will Europe Stand Up to U.S. Tariff Threats?
    How should Europe respond to the threat of 50 percent tariffs?
  • China
    The (Somewhat) Mysterious Surge in China’s Current Account Surplus
    China's trade surplus is rising.  China's reported current account surplus is rising even faster.  
  • Economics
    Why Didn’t Tariffs Push up the U.S. Dollar?
    Tariffs were supposed to push the dollar up. What happened?
  • China
    The Evolution of Global Trade in 2024
    A rebound in U.S. consumer imports fueled global trade, while Chinese import growth diverged from China’s export growth. Importers imported more, exporters exported more, and imbalances expanded.
  • Economics
    American Pharmaceutical Companies Still Aren’t Paying Tax in the U.S.
    The 2024 10-K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.